Target intelligence / Profile preview

Free heme (Ferriprotoporphyrin IX) (FP-IX)

Target
FP-IX
Molecular classification
Porphyrin, Metalloporphyrin, Metabolic byproduct, Other
01

Overview

Free heme, specifically ferriprotoporphyrin IX (FP-IX), is a potent toxin generated during the intraerythrocytic stage of the Plasmodium parasite's life cycle (Source: Nature Communications, 2013). As the parasite consumes host hemoglobin within its acidic digestive vacuole to acquire essential amino acids, it releases heme as a byproduct. To prevent heme-induced oxidative damage to its own membranes and enzymes, the parasite polymerizes the toxic monomeric heme into an inert, crystalline pigment known as hemozoin (Source: Science, 1991). This detoxification pathway is a critical vulnerability and serves as the primary target for several classes of antimalarial drugs. Quinoline-based drugs, such as chloroquine, bind to free heme and prevent its incorporation into hemozoin, while artemisinins are activated by heme to form carbon-centered radicals that damage parasite proteins (Source: Journal of Biological Chemistry, 2005). The accumulation of these toxic complexes leads to parasite death via membrane disruption and metabolic failure.

Other names
Ferriprotoporphyrin IXHematinLabile heme poolMonomeric hemeProtoporphyrin IX iron(III)Heme-iron pool
02

Mechanism of action

Inhibition of hemozoin biocrystallization; formation of toxic heme-drug complexes; induction of lipid peroxidation and oxidative damage (Source: PubMed PMID: 24123381, 16126312).

03

Biological functions

Hemoglobin degradation byproductOxidative stress inducerPro-oxidantRedox signaling
04

Disease associations

InfectionMalaria
05

Safety considerations

Drug resistance mediated by PfCRT and PfMDR1 transportersOxidative stress-related toxicity in host cellsTherapeutic challenges due to parasite sequestration in deep tissuesPotential for hemolysis in G6PD-deficient patients (indirectly related to treatment context)
06

Interacting drugs

Chloroquine

10 more in the full profile.

07

Biomarkers

Hemozoin levelsParasitemiaHeme-derived fluorescenceIntraerythrocytic labile iron pool

Beyond the preview

Go deeper on Free heme (Ferriprotoporphyrin IX) (FP-IX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free heme (Ferriprotoporphyrin IX) (FP-IX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call